IBG Beteiligungsgesellschaft Sachsen-Anhalt

IBG is a venture capital firm based in Magdeburg, Germany. Established in 2000, it specializes in seed to growth stage investments, focusing on technology-oriented companies within the German state of Saxony-Anhalt. IBG invests across various sectors including software, industrials, energy, healthcare, and biotechnology, typically allocating up to €10 million per company and aiming for minority stakes up to 24.9%.

Matthias Stübig

Managing Director

25 past transactions

livil

Venture Round in 2024
Livil is a company that specializes in developing automation software tailored for automotive applications. Their innovative software enables drivers to access essential office tools such as email, calendars, and instant messaging securely through voice input while driving. This technology enhances productivity by allowing users to manage complex work processes safely on the road. Additionally, Livil offers a toolkit for designing and delivering flexible employee benefits, which includes options for lifestyle, dental, and vision plans, catering to the diverse needs of modern workforces.

Intelligent fluids

Series B in 2023
Intelligent fluids develops high-performance cleaning fluids based on a patented technology that combines gentle ingredients to create dynamic phase fluids tailored to specific needs. The fluids achieve cleaning effects through physical mechanisms rather than chemical dissolution, making them safe for users, equipment, and the environment. They are designed for microelectronics, electronics, optics, printing, industrial maintenance, and building protection, and are used for stripping, removing dirt, residues, coatings, and lacquer. The company pursues ongoing product development for its own line and collaborates on joint development agreements and private-label projects. In addition to established applications, the technology has potential in fields such as functional skincare and dental cosmetics. The approach aims to improve process efficiency and sustainability by offering alternatives to conventional solvents.

InLine-Med

Seed Round in 2022
InLine-Med GmbH is a German company that specializes in developing assistance devices designed to aid radiologists in performing needle-based interventions, particularly in the context of cancer diagnosis and treatment. Founded in 2019 and based in Magdeburg, the company offers a range of products including navigation and assistance devices, surgical tools, needle alignment tools, and marker grids for anatomical orientation. InLine-Med's innovative approach integrates artificial intelligence with high-quality biopsy needles and guiding tools, enhancing the efficiency, accuracy, and safety of procedures. The company's solutions facilitate precise needle placement, addressing challenges posed by space constraints and the complexity of existing assistance devices. By utilizing AI algorithms, InLine-Med enables clinicians to visualize and plan interventions effectively, significantly reducing the number of punctures needed and minimizing risks for both patients and healthcare providers. The comprehensive suite of assistance tools and biopsy needles is competitively priced, making it accessible for clinicians seeking to improve their diagnostic and treatment capabilities.

Wingfield

Series A in 2022
Wingfield GmbH is a Hanover, Germany-based company founded in 2017 that specializes in developing smart court technology for tennis. The company offers a system that integrates hardware and artificial intelligence to transform any tennis court into a smart court. This innovative technology tracks scores, analyzes strokes, and provides personalized feedback to players immediately after matches or practice sessions. By making advanced game analytics accessible at a fraction of the cost of professional systems, Wingfield enables players and coaches to enhance training and review performance effectively, thereby elevating the overall tennis experience for amateurs.

livil

Seed Round in 2022
Livil is a company that specializes in developing automation software tailored for automotive applications. Their innovative software enables drivers to access essential office tools such as email, calendars, and instant messaging securely through voice input while driving. This technology enhances productivity by allowing users to manage complex work processes safely on the road. Additionally, Livil offers a toolkit for designing and delivering flexible employee benefits, which includes options for lifestyle, dental, and vision plans, catering to the diverse needs of modern workforces.

Baby Sweets

Seed Round in 2018
Baby Sweets is an online retailer specializing in unique and high-quality baby clothing and accessories. The company offers a diverse range of products, including bodysuits, rompers, pyjamas, caps, and themed baby accessories. By featuring both its own EU-made brands and various international brands, Baby Sweets aims to provide parents with a comprehensive selection of items essential for their child's early years. The focus on cute and eye-catching designs ensures that Baby Sweets stands out in the competitive baby fashion market, catering to the needs of modern families.

Coman Software

Venture Round in 2018
COMAN Software GmbH is a software development company specializing in project management solutions for the machine and plant construction industry. Founded in 2018 and based in Gardelegen, Germany, the company offers a comprehensive platform that facilitates the efficient management of construction projects. Its software features real-time data capture, project data importation, and status reporting, which enhance transparency and security throughout the project lifecycle. By streamlining processes and enabling digital information exchange, COMAN's solutions help reduce construction time and improve planning quality. The company also provides a mobile application for onsite information gathering and offers various services, including support, training, consulting, and project initialization. COMAN Software aims to improve collaboration and communication among teams, ultimately allowing businesses to deliver projects on time and within budget.

Lab-on-Fiber

Seed Round in 2018
Lab-on-Fiber develops, manufactures, and commercializes fiber-delivery and laser systems for minimally invasive surgery, including surgical and urology fiber probes. The company provides smart medical laser probes and systems designed to optimize energy delivery and safety during laser procedures. By measuring probe-surface temperature and shaping radiation profiles, Lab-on-Fiber aims to shorten operating times, improve treatment outcomes, and reduce the need for repeated applications. Based in Halle, Germany, the company targets procedures where precise light delivery and real-time feedback can enhance patient safety and procedural efficiency.

Urwahn

Venture Round in 2018
Urwahn designs and manufactures premium urban bicycles, integrating advanced technology such as lights and GPS. They collaborate with industrial partners to create innovative, lightweight bike frames and components tailored for daily commuting.

DCI Digital Car Institute

Venture Round in 2017
DCI Digital Car Institute GmbH, based in Halle, Germany, specializes in developing advanced scan sensor software and solutions for the digital assessment of vehicle valuations and inspection reports. The company offers a comprehensive digitization solution that captures complete 3D models of vehicles, facilitating damage assessment, vehicle valuation, and peer-to-peer marketing. Its innovative technology not only aids in determining vehicle value and condition but also supports new business models in automobile re-marketing. DCI serves a diverse clientele, including vehicle fleet managers, leasing companies, insurance providers, and used car dealers, making it a key player in the automotive technology sector.

TESVOLT

Series A in 2017
TESVOLT GmbH, founded in 2014 and based in Wittenberg, Germany, specializes in the manufacture of lithium battery storage systems aimed at the commercial and industrial sectors. The company is recognized as a leader in energy storage solutions within Germany and Europe, focusing on enabling businesses to reduce their energy dependency and contribute to the energy transition. TESVOLT produces intelligent storage systems with capacities ranging from 10 kilowatt-hours to multiple megawatt-hours, ensuring high quality and TÜV-certified safety. Its products can integrate with various renewable energy sources, including solar, wind, and biogas. The company operates a carbon-neutral gigafactory for series production and has received numerous accolades for its innovations, including the German Entrepreneur Award and the TOP 100 “Innovator of the Year.” Co-founders Daniel Hannemann and Simon Schandert leverage their extensive experience in the photovoltaic sector to advance the development of economical and efficient storage solutions.

Arzneimittelwerk Warngau

Series C in 2016
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

2tainment

Venture Round in 2016
Founded in 2014, 2tainment is a German-based company specializing in publishing video games. It develops and markets hardware and software entertainment products, with notable titles including Tech Corp, BIOTOPE – Aquarium Simulator, Air Missions: HIND, Super Street, Club Manager 2017, and Crashday. The company also offers PC, mobile, and video game accessories, and is involved in e-health solutions.

Arzneimittelwerk Warngau

Series B in 2015
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

Micropelt

Venture Round in 2012
Micropelt is a startup that evolved from a collaboration between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Freiburg, Germany. The company specializes in the development of thin film thermoelectric components, leveraging semiconductor manufacturing processes to create energy harvesting systems. These systems are designed to power micro-actuators and sensors, focusing specifically on thermoelectric cooling chips and thermogenerators. Micropelt's products are utilized in various applications, including chip spot cooling, biomedical devices, heating, ventilation, air-conditioning systems, and optical sensors. Their innovative technology aims to enhance temperature management in individual rooms while contributing to CO2 reduction and improving overall user comfort.

Vivoryon Therapeutics

Venture Round in 2012
Vivoryon Therapeutics is a biopharmaceutical company focused on developing therapeutic products for the treatment of Alzheimer's disease and cancer. Its lead product candidate, PQ912, has completed Phase IIb clinical trials for Alzheimer's disease. The company also has preclinical development products targeting cancer and is exploring monoclonal antibody therapies.

TME Pharma

Series D in 2010
Founded in 1997, TME Pharma is a Berlin-based biopharmaceutical company specializing in the development of biostable aptamers and substances derived from mirror image nucleic acids. Its lead product, NOX-A12, targets the tumor microenvironment to enhance cancer therapy effectiveness.

Vivoryon Therapeutics

Series B in 2009
Vivoryon Therapeutics is a biopharmaceutical company focused on developing therapeutic products for the treatment of Alzheimer's disease and cancer. Its lead product candidate, PQ912, has completed Phase IIb clinical trials for Alzheimer's disease. The company also has preclinical development products targeting cancer and is exploring monoclonal antibody therapies.

KeyNeurotek Pharmaceuticals

Series C in 2009
KeyNeurotek is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases.

EUCODIS Bioscience

Venture Round in 2007
Founded in 2007, EUCODIS Bioscience specializes in the development and manufacturing of enzyme solutions for diverse industries such as biopharma, fine chemicals, cosmetics, food, feed, and more. Its portfolio includes lipases, peroxidases, phospholipase D, nitril hydratases, and other enzymes, catering to applications like chiral resolution, ester synthesis, fat production, hydrolysis/esterification, emollient ester synthesis, and bioplastic modification refinement.

20/10 Perfect Vision

Venture Round in 2007
20/10 Perfect Vision has develops, manufactures and markets innovative technologies for raising refractive surgery well beyond current expectations. The company's FEMTEC femtosecond laser workstation is set to revolutionize the ophthalmic surgery market, while keeping ease-of-use and patient safety as primary objectives.

TME Pharma

Series C in 2007
Founded in 1997, TME Pharma is a Berlin-based biopharmaceutical company specializing in the development of biostable aptamers and substances derived from mirror image nucleic acids. Its lead product, NOX-A12, targets the tumor microenvironment to enhance cancer therapy effectiveness.

MetraTec

Seed Round in 2006
MetraTec GmbH, established in 2006 and headquartered in Magdeburg, Germany, specializes in manufacturing and supplying Radio Frequency Identification (RFID) hardware products. Its portfolio includes HF and UHF readers, gates, starter kits, RFID readers/writers, multiplexers, antennas, transponders, and modules. MetraTec's products cater to diverse industries such as logistics, retail, healthcare, and security, serving applications like access control, document management, payment systems, and indoor localization. The company also offers custom solutions tailored to specific client needs, primarily serving system integrators, OEM customers, and research institutes worldwide, with a focus on Europe.

Curacyte AG

Series C in 2005
Curacyte GmbH is a biopharmaceutical company based in Munich, Germany, founded in 2001. It specializes in developing innovative therapeutics for acute and critical care, focusing on areas such as hematology, antithrombosis, and oncology. The company's research efforts aim to create advanced biopharmaceutics that address urgent medical needs, providing new treatment options for patients with critical diseases.

CSG Solar

Venture Round in 2005
CSG Solar is one of the leading players in thin-film solar technology. The company gets its name (Crystalline Silicon on Glass) from its technology, in which an extremely thin layer of silicon is deposited directly onto a glass sheet. This captures the already proven qualities of silicon in solar cells while significantly reducing the total amount of silicon required.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.